Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Ongoing research and innovation are crucial for improving skin care and treatment.

New treatments offer hope for better managing hidradenitis suppurativa.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.